The evidence for puberty blockers and cross-sex hormones for young people with gender dysphoria is “remarkably weak”. That’s according to the Cass Review, a new in-depth report commissioned by NHS England.
As you might imagine, the report’s conclusions have been somewhat controversial. In this paid-subscriber-only episode of The Studies Show, Tom and Stuart read through the Cass Report, consider the arguments of its critics, and try to put the whole thing in context.
Listen to this episode with a 7-day free trial
Subscribe to The Studies Show Podcast to listen to this post and get 7 days of free access to the full post archives.
